MEI Pharma, Inc. (MEIP)

MEI Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	161	19	44	81	321	438
Market Cap Growth	-45.25%	-55.77%	-45.58%	-74.89%	-26.70%	145.63%
Enterprise Value	140	-25	-55	-78	165	345
Last Close Price	5.14	2.91	5.11	9.40	44.28	64.16
PE Ratio	-	1.09	-	-	-	-
PS Ratio	-	0.30	0.90	1.98	9.22	15.77
PB Ratio	1.75	0.59	1.78	1.54	6.49	5.68
P/TBV Ratio	8.22	0.59	1.78	1.54	6.49	5.68
P/FCF Ratio	-	-	-	-	-	13.12
P/OCF Ratio	-	-	-	-	-	12.78
EV/Sales Ratio	-	-	-	-	4.74	12.43
EV/FCF Ratio	-	-	-	-	-	10.34
Debt / Equity Ratio	-	-	0.52	0.18	0.17	-
Asset Turnover	-	0.81	0.33	0.23	0.18	0.19
Quick Ratio	16.54	4.59	4.96	6.68	7.97	13.49
Current Ratio	16.78	4.88	5.29	6.84	8.15	15.17
Return on Equity (ROE)	-89.73%	61.68%	-82.66%	-106.90%	-65.31%	-75.48%
Return on Assets (ROA)	-23.23%	20.04%	-13.88%	-26.81%	-19.68%	-10.99%
Return on Capital (ROIC)	-26.00%	46.18%	-41.70%	-78.75%	-56.02%	-25.70%
Return on Capital Employed (ROCE)	-	78.70%	-	-	-	-
Earnings Yield	-19.72%	91.69%	-72.62%	-67.60%	-12.88%	-10.78%
FCF Yield	-22.66%	-260.35%	-119.79%	-61.11%	-10.18%	7.62%
Buyback Yield / Dilution	-	-	-6.49%	-9.31%	-25.69%	-25.83%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q